Catherine Chappell, MD, MSc

Faculty, Department of Obstetrics, Gynecology and Reproductive Sciences


Dr. Chappell’s research focuses on improving reproductive health outcomes in women living with chronic viral infections, such as HIV or Hepatitis C. She is currently evaluating dose-escalation of the etonogestrel implant in women living with HIV taking efavirenz-based ART in collaboration with the Infectious Disease Institute in Kampala, Uganda. In Pittsburgh, her team is conducting the pharmacokinetic and safety study of ledipasvir and sofosbuvir for hepatitis C treatment during pregnancy.

To view Dr. Chappell’s studies, please visit her page on the Microbicide Trials Network.

To view Dr. Chappell’s publications, click here.